Iterum Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ITERUM THERAP, and what generic and branded alternatives to ITERUM THERAP drugs are available?
ITERUM THERAP has one approved drug.
Summary for Iterum Therap
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Iterum Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iterum Therap | ORLYNVAH | probenecid; sulopenem etzadroxil | TABLET;ORAL | 213972-001 | Oct 25, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
